Status:
COMPLETED
CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19)
Lead Sponsor:
University of Oklahoma
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Conditions:
COVID-19
Vaccine Refusal
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Oklahoma has high COVID-19 incidence, particularly among underserved minority and rural Oklahomans. Oklahoman's are also reporting SARS-CoV-2 vaccine hesitancy and signs of slowing vaccine uptake, wit...
Detailed Description
This proposal unites academic and community partners to solve a dire need for SARS-CoV-2 vaccine uptake in rural, underserved minority, and at-risk populations. Oklahoma has high COVID-19 incidence, h...
Eligibility Criteria
Inclusion
- 18 years of age and older
- Must be eligible to receive a COVID-19 vaccine dose at the time of consent based on the following criteria:
- a. Eligible for one bivalent mRNA vaccine i. No previous doses of any COVID-19 vaccine ii. At least 8 weeks since a previous vaccine dose of any manufacturer b. Eligible for second bivalent mRNA vaccine i. Adults 65 year of age and older can receive one additional bivalent mRNA vaccine at least 4 months after the first dose of a bivalent mRNA vaccine.
- ii. Those who are immunocompromised can receive one additional bivalent mRNA vaccine at least 2 months after the first dose of a bivalent mRNA vaccine.
- Ability to read and speak English
Exclusion
- Those who have received all eligible doses of any approved COVID-19 vaccine.
- Those with active COVID-19 disease (either through self-reported positive test within the last 10 days or viral test at the event if available).
Key Trial Info
Start Date :
March 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 26 2023
Estimated Enrollment :
312 Patients enrolled
Trial Details
Trial ID
NCT05236270
Start Date
March 25 2022
End Date
August 26 2023
Last Update
May 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oklahoma Clinical and Translational Science Institute
Oklahoma City, Oklahoma, United States, 73104